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Abstract To investigate the migraine locus around the C19p13 region through analysis of the NOTCH3 gene (C19p13.2-
p13.1), previously shown to be a gene involved in CADASIL and the TNFSF7 gene (C19p13), homologous to the ligands 
of TNF-alpha and TNF-beta, genes that have previously been associated with migraine. The NOTCH3 gene was analysed 
by sequencing all exons with known CADASIL mutations in a typical (non-familial hemiplegic) migraine family (MF1) 
that has previously been shown to be linked to C19p13. The TNFSF7 gene was investigated through SNP association 
analysis using a matched case-control migraine population. NOTCH3 gene sequencing results for affected members of 
MF1 proved to be negative for all known sequence variants giving rise to mutations for CADASIL. TNFSF7 gene chi-
square results showed non-significant P values across all populations tested against controls, except for the MO subgroup 
which displayed a possible association with the TNFSF7 SNP (genotype, allele analysis P = 0.036, P = 0.017 respec-
tively). Our results suggest that common migraine is not caused by any known CADASIL mutations in the NOTCH3 gene 
of interest. However, the TNFSF7 gene displayed signs of involvement in a MO affected population and indicates that 
further independent studies of this marker are warranted. 
Keywords: Typical migraine, NOTCH3, CADASIL, TNFSF7, C19p13, MO. 
INTRODUCTION  
  Typical migraine is a common debilitating disorder af-
fecting approximately 12% of the Western population [1]. A 
large US epidemiological study indicated that the disease 
affects around 18% of women and 12 % of men in the over-
all population [2]. The disease has two main subtypes, mi-
graine without aura (MO) affecting ~ 73% and migraine with 
aura (MA) affecting about 33%. Migraine with aura is de-
fined as the more severe type and both subtypes can occur 
within the same family. The number of genes involved in 
common migraine is unknown; although genes for a rare 
severe sub-type of migraine Familial Hemplegic Migraine 
(FHM) have been identified on chromosome 19 [3] and re-
cently FHM type 2 has been identified on chromosome 1 [4]. 
  Mutations in the neuronal calcium channel gene 
(CACNA1A) on 19p13.1-13.2 have been shown to cause 
FHM [3]. Calcium channel genes may also be involved in 
typical migraine (MA and MO) as some studies have indi-
cated that the FHM locus may contribute to migraine with 
and without aura [5]. We have previously reported linkage in 
one large typical migraine family [6] to the CACNA1A re-
gion on chr19. Also in a study by Terwindt et al. (1998) [7] 
the authors detected an FHM mutation in the CACNA1A 
gene in a typical migraine patient with MA, suggesting that 
FHM may be a rare and severe form of MA. 
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  Typical migraine has been extensively studied on chro-
mosome 19 showing positive linkage to causal markers in 
the C19p13 area [5,6,8-10], but only in FHM has the chro-
mosome 19 gene and mutations within been identified [3]. 
The NOTCH3 gene on C19p13.2-p13.1 has previously been 
shown to be a gene involved in CADASIL (cerebral autoso-
mal dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy) [11]. CADASIL is an inherited stroke 
syndrome that leads to dementia. The key features of the 
disorder are migraine, recurrent subcortical events, and de-
mentia, in association with diffuse white matter abnormali-
ties on neuroimaging [12]. The gene encodes a large trans-
membrane receptor [13], which has been shown to be ex-
pressed in vascular smooth muscle cells in adult human tis-
sues [14]. In a study by Joutel et al. 1997 [13] this large 
gene, containing 33 exons, was found to contain a cluster of 
mutations in exons 3 and 4 affecting 64% (32/50) of tested 
patients with the CADASIL disorder. Of the other 36% of 
CADASIL sufferers, 26% (13/50) have mutations in exons 
2,5,11,14,18,19,22 or 23 and the other 10% (5/50) had no 
detectable mutation in the NOTCH3 gene [13]. Mutations 
identified to date in NOTCH3 have all been missense muta-
tions involving a loss or gain of a cysteine amino acid resi-
due [13].  
  The NOTCH3 gene may also be implicated in migraine, 
as migraine shows some symptomatic overlap with CA-
DASIL. This has been suggested from studies performed by 
Hutchinson et al. (1995) [15] and Verin et al. (1995) [16] 
where the authors have found some correlations between the 
two disorders. Hutchinson et al. (1995) [15] used MRI to 2    The Open Neurology Journal, 2008, Volume 2  Smith et al. 
study 15 members of an Irish family, 10 of whom had evi-
dence of CADASIL. Five members of this family had 
hemiplegic migraine. They proposed that hemiplegic mi-
graine may be an allelic disorder to CADASIL. Migraine 
with aura (MA) is also included as one of the clinical hall-
marks of CADASIL, with many CADASIL patients showing 
an unusually high frequency of attacks of migraine with 
atypical aura [17]. In 2003, Oberstein et al. [18] found that 
among 6 individuals who carried a mutation in the NOTCH3 
gene, there was an increase in white matter hyperintensities 
on brain MRI, compared to controls and migraine with aura 
was more common in these subjects than in their controls. In 
addition, a recent association study by Schwaag et al. identi-
fied a significant association of the synonymous rs1043994 
polymorphism with migraine [19]. However, not all 
NOTCH3 mutations may be involved in migraine, as an as-
sociation study by Borroni et al. [20] indicated that the that 
functional polymorphism T6746C of NOTCH3 did not have 
any association with migraine in the tested Italian popula-
tion. 
  The TNFSF7 gene (Tumor Necrosis Factor Ligand Su-
perfamily, member 7) localized on C19p13 is a surface anti-
gen found on activated, but not resting, T and B lymphocytes 
[21]. It is a 19 amino acid protein containing a 20-amino acid 
hydrophilic N-terminal domain that lacks a signal sequence; 
an 18-amino acid hydrophobic region that presumably func-
tions as a transmembrane anchor; and a C-terminal domain 
that contains 2 potential N-linked glycosylation sites is ex-
tracellular classifying TNFSF7 as a type II transmembrane 
protein. TNFSF7 is homologous to the ligands of the TNF 
receptor family, including TNF-alpha, TNF-beta and the 
CD40 ligand, showing 19 to 24% amino acid sequence iden-
tity in the extracellular region. [21]. TNF-alpha and TNF-
beta have both been previously associated with migraine. 
Rainero et al. 2004 [22], recently found an association be-
tween the tumor necrosis factor-alpha -308 G/A gene poly-
morphism and migraine. In a group of 299 migraine patients 
and 306 control subjects, the association of this polymor-
phism with the occurrence and clinical characteristics of mi-
graine was tested. They found that homozygosity for the G 
allele was associated with an increased risk of migraine 
(odds ratio [OR] = 2.85, p < 0.001) [22]. Also Empl et al. 
2003 [23] suggested that TNF-alpha could contribute to mi-
graine pain generation and in their study of TNF-alpha and 
its soluble receptor sTNF-RI, they found that migraine pa-
tients tended to have less concentration levels of sTNF-RI 
(794 +/- 158 pg/ml) than controls (945 +/- 137 pg/ml) [23]. 
The authors suggested that if TNF-alpha plays a role in mi-
graine physiopathology, migraine patients may lack suffi-
cient antagonistic sTNF-RI to neutralize hyperalgesic TNF-
alpha during a migraine attack, causing pain [23]. The TNF-
beta gene has been associated with migraine without aura. 
Trabace et al. 2002 [24] found the frequency of the TNFB*2 
allele of the TNF-beta gene was significantly increased in 
patients with migraine without aura as compared with the 
control group (78.72% versus 61.4%, Pc =.004) [24]. They 
stated that carriage of the TNFB*2 allele confers a high risk 
for the development of migraine without aura. The data sup-
ported the hypothesis that TNF-beta could be a susceptibility 
gene in migraine without aura [24]. Since TNFSF7 is 
homologous to the ligands of the TNF receptor family i.e. 
TNF-alpha and TNF-beta, (and is localized to a migraine 
susceptibility area at C19p13) we decided to investigate this 
gene for association with migraine.  
  This study investigated the migraine susceptibility locus 
C19p13 by testing two genes, from this genomic region, that 
may possibly be involved in the disorder. The NOTCH3 
gene was analysed by sequencing all exons with known 
CADASIL mutations through a family previously linked to 
C19p13 [6]. The TNFSF7 gene was also investigated using 
SNP case-control association analysis in a population of mi-
graineurs and matched controls. 
MATERIALS AND METHODOLOGY 
Subjects 
  The subjects who participated in this study were all of 
Australian Caucasian origin and were diagnosed for mi-
graine by a detailed questionnaire and a clinical neurologist 
in accordance to the International Headache Society guide-
lines [25]. The control population consisted of individuals 
who indicated on a questionnaire that they had never suf-
fered from migraine or any similar condition and that none 
of their first or second degree relatives suffered from mi-
graine or similar conditions. This research was approved by 
the Griffith University Ethics Committee and all subjects 
participating in the study gave consent. Blood samples for 
the pedigree population as well as the association population 
were collected through the Genomics Research Centre clinic. 
Genomic DNA, from these patients, was extracted utilizing 
DNA extraction methods described previously [26, 27]. 
 
 
 
 
 
 
 
 
 
Fig. (1). Migraine family 1 (MF1) Individuals in black have been diagnosed as MA or MO. Non-migraine individuals are in clear. Samples 
tested are indicated by an arrow. Samples  indicated by asteric (*) were sequenced for all known CADASIL mutations in the NOTCH3 gene. Investigation of the NOTCH3 and TNFSF7 Genes on C19p13  The Open Neurology Journal, 2008, Volume 2    3 
Table 1.  A List of all Published Mutations of CADASIL from the Notch3 Gene (Human Gene Mutation Data Base Cardiff 
Accession Number  Codon  Exon  Nucleotide  Amino Acid 
CM971054 49  2  TGT-TAT  Cys-Tyr 
CM003012 54  2  tCGT-TGT  Arg-Cys 
CM961042 71  3 TGGg-TGT  Trp-Cys 
CM023649 76  3 gTGT-CGT  Cys-Arg 
CM971055 90  3  cCGT-TGT  Arg-Cys 
CM001263 93  3  TGC-TTC  Cys-Phe 
CM023650 93  3  TGC-TAC  Cys-Tyr 
CM971056 110  3  cCGT-TGT  Arg-Cys 
CM001264 117  4  TGC-TTC  Cys-Phe 
CM001265 123  4  TGC-TTC  Cys-Phe 
CM003013 123  4  TGC-TAC  Cys-Tyr 
CM023651 128  4  TGT-TAT  Cys-Tyr 
CM971057 133  4  cCGC-TGC  Arg-Cys 
CM022434 134  4  TGCt-TGG  Cys-Trp 
CM014589 134  4  TGC-TAC  Cys-Tyr 
CM971058 141  4  aCGC-TGC  Arg-Cys 
CM023652 142  4  TTC-TGC  Phe-Cys 
CM003947 144  4  TGC-TTC  Cys-Phe 
CM001266 144  4  TGC-TCC  Cys-Ser 
CM001267 144  4  TGC-TAC  Cys-Tyr 
CM971059 146  4  cTGC-CGC  Cys-Arg 
CM001268 150  4  TAC-TGC  Tyr-Cys 
CM971060 153  4  cCGC-TGC  Arg-Cys 
CM003014 162  4  gTGC-AGC  Cys-Ser 
CM961043 169  4  cCGC-TGC  Arg-Cys 
CM971061 171  4  tGGT-TGT  Gly-Cys 
CM033795 174  4  cTGC-CGC  Cys-Arg 
CM014211 174  4  TGC-TTC  Cys-Phe 
CM001269 174  4  TGC-TAC  Cys-Tyr 
CM003015 180  4  TCC-TGC  Ser-Cys 
CM961044 182  4  cCGC-TGC  Arg-Cys 
CM001270 183  4  cTGC-CGC  Cys-Arg 
CM001271 183  4  cTGC-AGC  Cys-Ser 
CM971062 185  4  gTGT-CGT  Cys-Arg 
CM014590 185  4  gTGT-GGT  Cys-Gly 
CM023653 194  4  aTGT-CGT  Cys-Arg 
CM001272 194  4  TGT-TTT  Cys-Phe 4    The Open Neurology Journal, 2008, Volume 2  Smith et al. 
(Table 1). Contd….. 
Accession Number  Codon  Exon  Nucleotide  Amino Acid 
CM003016 194  4  TGT-TAT  Cys-Tyr 
CM003017 206  4  TGC-TAC  Cys-Tyr 
CM003018 207  4  cCGT-TGT  Arg-Cys 
CM971063 212  4  cTGC-AGC  Cys-Ser 
CM033796 213  4  AGG-AAG Arg-Lys 
CM971064 222  4  cTGT-GGT  Cys-Gly 
CM023654 222  4  TGT-TAT  Cys-Tyr 
CM971065 224  4  TGT-TAT  Cys-Tyr 
CM023655 233  5  tTGT-AGT  Cys-Ser 
CM023656 251  5  aTGC-CGC  Cys-Arg 
CM971066 258  5  TAT-TGT  Tyr-Cys 
CM014070 332  6  cCGC-TGC  Arg-Cys 
CM023657 420  8  cGGT-TGT  Gly-Cys 
CM014591 428  8  TGT-TCT  Cys-Ser 
CM023658 440  8  cTGC-GGC  Cys-Gly 
CM023659 449  8  cCGC-TGC  Arg-Cys 
CM021648 455  8  cTGT-CGT  Cys-Arg 
CM961045 542  11  TGT-TAT  Cys-Tyr 
CM994179 544  11  tCGC-TGC  Arg-Cys 
CM961046 558  11  tCGC-TGC  Arg-Cys 
CM961047 578  11 aCGC-TGC  Arg-Cys 
CM003019 607  11 cCGC-TGC  Arg-Cys 
CM971067 728  14 cCGC-TGC  Arg-Cys 
CM023660 953  18 cGGC-TGC  Gly-Cys 
CM003020 984  18  TTC-TGC  Phe-Cys 
CM971068 985  18 cCGC-TGC  Arg-Cys 
CM971069 1006  19  cCGC-TGC  Arg-Cys 
CM994180 1015  19  cTGC-CGC  Cys-Arg 
CM023661 1021  19  TAT-TGT  Tyr-Cys 
CM971070 1031  19  aCGC-TGC  Arg-Cys 
CM014592 1058  20  gGGT-TGT  Gly-Cys 
CM971071 1231  22  cCGT-TGT  Arg-Cys 
CM961048 1261  23  gTGC-CGC  Cys-Arg 
www.uwcm.ac.uk/uwcm/mg/ns/1/361163.html). 
  For mutation analysis, 12 affected DNA samples ob-
tained from migraine family 1 (MF1) (Fig. 1), a pedigree 
showing linkage to 19p13 in a previous study [6], were 
screened for the known exon 3 and exon 4 CADASIL muta-
tions (Table 1) in the NOTCH3 gene. The pedigree family 
members tested (indicated by an arrow in Fig. 1) were mi-
graine sufferers of which eight were diagnosed MA and four 
MO affected, two were males (both MA affected) and ten 
females (six MA and four MO affected). The age of these 
migraine affected pedigree members range from 31 to 87 
years.  Investigation of the NOTCH3 and TNFSF7 Genes on C19p13  The Open Neurology Journal, 2008, Volume 2    5 
  Secondly 3 of the 12 family members, from three sepa-
rate branches of MF1 (Fig. 1), were further screened by se-
quencing the rest of all known exons containing CADASIL 
mutations in the NOTCH3 gene (Table 1). The association 
study included a case-control population of 220 migraineurs 
and 220 sex, age and ethnicity matched controls. 
Table  2.  Primer Sequences Utilized for Sequencing of the 
NOTCH3 for the CADASIL Mutations 
NOTCH3 region  Sequence 5'->3' 
Exon 2 
F-TCCTCCACCTTCCTTCAC 
R-ACACACAGGGCCCACTGGT 
Exon 3 
F-TGTGCTGCCCAACCAAGCCA 
R-ACTGACCACACCCCCGACTA 
Exon 4 
F-TAGTCGGGGGTGTGGTCAGT 
R-CCTCTGACTCTCCTGAGTAG 
Exon 5 
F-TGACCATCCTTGCCCCCTT 
R-CTGGCCTGTGGCACACAGAT 
Exon 6 
F-TGGACTGCTGCATCTGTGTG 
R-ACACGCCTGTGGCACAGTCA 
 
Exon 8 
F-ATCGCACTCCATCCGGCA 
R–ACCCACCTGCCATACAGA 
Exon 11A 
F-ATTGGTCCGAGGCCTCACTT 
R–ACCTGGCTCTCGCAGCGTGT 
Exon 11B 
F-CCATTCCCAACCCCTCTGTG 
R–TGCCTGTGCTCCTGGCTACA 
Exon 14 
F-TCCCTGGCCTGACTACCTTC 
R–CTGCAGAGGGAAGGTGAGGT 
 
Exon 18 
F-GATCCTCCCTCCCACTCCTT 
R–AGGTCCCCAGTAACTCCA 
 
Exon 19 
F-ACTGACTCTAAGTGCTTCCC 
R–AGCAGGAGGTACGTGCATGA 
Exon 20 
F-TGTTCCTGTGCCACTCTCCT 
R–ACCTCCTCTTCCCTCTCCT 
Exon 22A 
F-TTCCTCTTGACCACCCCTCG 
R–TGGCAGGCACCTGAGCGACA 
Exon 22B 
F-CAGGATACACTGGTTTGCGC 
R–TGCCACGTTATGGATCAGCC 
Exon 23 
F-GATCTACATGCTCCCGCTCG 
R–TACTCCTCCTCCATAGGCCG 
 
Mutation Analysis 
  Mutation screening was performed by direct sequencing 
of exons, exhibiting known CADASIL mutations, in the 
NOTCH3 gene utilizing genomic DNA samples from mi-
graine affected pedigree members of MF1 (Fig. 1). Tem-
plates of PCR DNA fragments were generated in the forward 
and reverse direction using standard PCR (outlined below in 
association study) and sequencing conditions (ABI proto-
cols). Table 2 shows a list of exon primer sequences used in 
sequencing for the known mutations. The resulting products 
were electrophoresed on an ABI377 Sequencer (Applied 
Biosystems) and analysed using Sequencher software (Gene 
Codes Corporation) against a control sequence (Accession 
number: NM 000435).  
Association Analysis 
  The TNFSF7 SNP, for association analysis, was selected 
utilizing the software SNPbrowser
TM (ABI) and Ensembl 
Genome Browser, NCBI SNP databases. This synonymous 
coding SNP (refSNP 1862511, C/T variation, codes for 
amino acid Cysteine) is contained within exon 3 of the 
TNFSF7 gene with a minor allele frequency of approxi-
mately 0.3 (T allele). Primer sequences for the SNP were 
designed by utilizing Primer Express
TM v 2.0 software (ABI) 
and are displayed below. 
Forward primer: 5’- AGCACTGGGCCGCTCC – 3’ 
Reverse primer:  
5’- CAAAAGTGTCCCAGTGAGGTTG – 3’ 
  The PCR reaction utilized final concentrations of 
1.75mM, 0.2M, 200M, 1X and 1U for MgCl2, Primers, 
dNTPs, 10x Buffer and Taq polymerase, respectively. Ap-
proximately 40ng of DNA per reaction was used in the PCR. 
Cycling conditions for PCR consisted of 94°C for 4 minutes, 
then 35 cycles of 94°C for 1 minute and 60°C for 1 minute. 
The final PCR extension consisted of 72°C for 2 minutes. 
  SNP genotype analysis was performed using a restriction 
enzyme site that overlapped the SNP site (CTCCTC). Re-
striction enzyme digest conditions utilized 10ul of PCR 
product and a 10ul mix of 3U of restriction enzyme with 1X 
enzyme buffer and H2O. Digest products were loaded and 
electrophoresised on 3% standard agarose gels running at 
110 volts for 1 hour. The genotyping allele set and corre-
sponding restriction digest fragment size consisted of: C al-
lele = 192,100bp, T allele = 292bp, C/T = 292,192,100bp. 
  Genotype and allele frequencies for the SNP variant were 
calculated from observed genotype counts. The expected 
genotype proportions according to the Hardy-Weinberg law 
were calculated and compared to observed genotypes as a 
control for systematic genotyping error and population strati-
fication. Genotype and allele frequencies were initially as-
sessed for association with migraine, then MA and MO 
populations were investigated using conventional contin-
gency table analyses incorporating the standard chi-squared 
test for independence. 
RESULTS 
Mutation Analysis 
  The DNA samples from MF1 that were examined for 
NOTCH3 – CADASIL mutations were from individuals 
affected with typical migraine in a pedigree previously 
shown to be linked to chromosome 19p13 [6]. Firstly 12 
members from MF1 were screened for exon 3 and 4 muta-
tions of the NOTCH3 gene using direct sequencing methods 
- a diagnostic screening process that is utilized first in detect-
ing CADASIL mutations. The results revealed no variations 6    The Open Neurology Journal, 2008, Volume 2  Smith et al. 
or mutations detected in the sequence of the two exons 
within the twelve migraine family one DNA templates. Sec-
ondly, 3 members of MF1 were chosen from three separate 
pedigree branches to test for the rest of the exons with 
known CADASIL mutations in NOTCH3 (Table 1). These 
results also proved to be negative with no known sequence 
variants detected in the extended exon sequence analysis. 
The sequencing results displayed that of a normal coding 
sequence for the NOTCH3 gene (Accession number: NM 
000435). 
Association Analysis 
  Total distribution of the rs1862511  SNP genotype and 
allele frequencies of the TNFSF7 gene in Migraine (Total), 
MA, MO and Control Groups are displayed in Table 3. 
  The results of chi-square analysis of the TNFSF7 SNP 
(rs1862511) are displayed in Table 4. All population data of 
observed genotypes fitted the expected genotype proportions 
according to the Hardy-Weinberg law. Chi-square results 
showed non-significant P values (P > 0.05) across all popu-
lations tested against controls. The only exception was for 
the MO subgroup which displayed a positive association for 
both alleles (P = 0.017) and genotypes (P = 0.036) for the 
TNFSF7 SNP (Table 4). 
Table 3.  Total Distribution for rs1862511 SNP Genotype and 
Allele Frequencies of the TNFSF7 Gene in Migraine 
(Total), MA, MO and Control Groups 
 SNP  Genotypes 
Group C/C  C/T  T/T 
Total Migraine  116(53%) 88(40%)  15(7%) 
MA 65(49%)  59(44%)  10(7%) 
MO 51(60%)  29(34%)  5(6%) 
Control 73(43%) 81(48%)  16(9%) 
 SNP  Alleles 
Group C  T  
Total Migraine  320(73%) 118(27%)   
MA 189(71%)  79(29%)   
MO 131(77%)  39(23%)   
Control 227(67%) 113(33%)   
 
Table 4.  Chi-Squared  (
2) Analysis of all Migraine Groups 
Against Controls for rs1862511 SNP of the TNFSF7 Gene 
 Frequency  Comparison 
Group  Genotypes   Alleles  
Total migraine 
 
2 = 4.00, P = 0.136  
2 = 3.63, P = 0.057 
MA  
2 = 1.06, P = 0.589  
2 = 0.98, P = 0.322 
MO  
2 = 6.65, P = 0.036  
2 = 5.74, P = 0.017 
 
DISCUSSION 
  The procedure for genetic diagnostic testing for CA-
DASIL mutations has recently been revised. We undertook a 
similar approach to this revision in testing for these muta-
tions in common migraine. A study in Britain [28], found 15 
different point mutations in the NOTCH3 gene in 48 fami-
lies, 73% of which were in exon 4, 8% in exon 3, and 6% in 
each of exons 5 and 6. The authors suggested that on the 
basis of this spectrum the suggested protocol for genetic di-
agnostic testing for CADASIL would be to screen exon 4 
and proceed to mutational screening of exons 3, 5, and 6 
where indicated [28]. A similar approach can be undertaken 
in diagnostic testing for other diseases with known mutations 
in genes causing a disorder, including FHM whereby two 
genes and corresponding mutations have been identified in 
causing this rare subtype of migraine.  
  The NOTCH3 gene has been localised to C19p13, a re-
gion showing linkage to MF1 a typical (not FHM) migraine 
pedigree. Our sequencing results for this gene, specifically 
testing exons with known CADASIL mutations proved to be 
negative. These results indicate that common migraine, at 
least in this pedigree, is not caused by mutations in the 
NOTCH3 gene. 
  TNF-alpha and TNF-beta have both been previously as-
sociated with migraine [22, 24]. Since TNFSF7 is localized 
to the same migraine susceptibility area at C19p13 and 
shows homology to the ligands of the TNF-alpha and TNF-
beta genes (both localized at C6p21.3), we decided to also 
investigate this gene for involvement in migraine. A suitable 
informative SNP (rs1862511) was selected for an association 
analysis study involving a matched case-control population. 
Overall chi-square results comparing migraine (total) and 
MA sub-populations with sex, age and ethnicity matched 
controls proved to be non-significant, with P values of P = 
0.136, P = 0.589 respectively obtained (Table 4). These val-
ues were both above the threshold of P<0.05 for signifi-
cance. However, the MO subgroup displayed signs of possi-
ble involvement of the TNFSF7 SNP with this sub-
population compared to controls. P values for genotype and 
allele analysis were P = 0.036 and P = 0.017, respectively 
(Table 4). These results indicate that this genetic variant may 
play a role in migraine without aura and warrant further in-
vestigation.  
  Overall the results presented here do not support a 
relationship between NOTCH3 and common migraine. 
Although CADASIL patients often display migraine 
symptoms there was no evidence that CADASIL mutations 
from the NOTCH3 gene are involved in typical migraine in 
our C19p13 linked [6] migraine family samples. However, 
this does not discount the possibility of a role for mutations 
in the as yet unscreened exons in NOTCH3 in migraine sus-
ceptibility. The TNFSF7 gene also localized to the C19p13 
region did not show any association with typical migraine or 
the MA subtype, however a weak association was found with 
MO affected individuals. Since this gene shows homology to 
the TNF receptor family and both TNF-alpha and beta have 
previously shown association with typical migraine [22, 24], 
the TNFSF7 gene (localized on C19p13, a migraine linked 
region, see [5,6,8-10]) was investigated in migraine. Our 
association study showed signs of possible involvement of 
this gene with the MO subtype only, but clearly more work Investigation of the NOTCH3 and TNFSF7 Genes on C19p13  The Open Neurology Journal, 2008, Volume 2    7 
needs to be done in increasing sample size numbers and also 
confirmation from other research groups to give an indica-
tion of a relationship of this gene to migraine without aura.  
CONCLUSION 
  It is clear that typical migraine is a complex disorder that 
may involve several genes on various chromosomes. Since 
the C19p13 region has been implicated in a number of stud-
ies it is considered a ‘hotspot’ for the disorder. More exten-
sive sequencing of the NOTCH 3 gene that may identify 
novel mutations that relate to migraine should be undertaken. 
Further studies need to be performed with TNFSF7 and MO 
affected individuals and also other possible TNF receptor 
family homologues on C19p13, such as TNFSF9 (C19p13.3) 
and TNFSF14 (C19p13.3) should be tested for migraine in-
volvement. It may be useful to explore the TNF receptor-
migraine interaction further by studying these genes local-
ized to the C19p13 region.  
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